Standard BioTools Inc. (LAB) revenue

Revenue · fiscal 2025
$85.33M

Standard BioTools Inc. (LAB) reported revenue of $85.33M in fiscal 2025 (the year ended December 31, 2025). That is 6.2% lower than the $91.01M of fiscal 2024. Figures as of 17 Nov 2026, 21:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$85.33M
Change on fiscal 2024
−6.2%
Growth, 5 years
−9.2% a year
Growth, 10 years
−2.9% a year
Highest on record
$138.14Mfiscal 2020
Lowest on record
$25.41Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Standard BioTools Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 9.2% a year; over ten years the rate was −2.9% a year. Across the 17 fiscal years on record (2009–2025), the highest was $138.14M in fiscal 2020 and the lowest $25.41M in fiscal 2009.

History · 17 fiscal years

Revenue by fiscal year

Standard BioTools Inc. revenue, year by year

Standard BioTools Inc. (LAB) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$85.33M 6.2% down
2024$91.01M 14.4% down
2023$106.34M 8.6% up
2022$97.95M 25.0% down
2021$130.58M 5.5% down
2020$138.14M 17.8% up
2019$117.24M 3.8% up
2018$112.96M 10.8% up
2017$101.94M 2.4% down
2016$104.45M 8.9% down
2015$114.71M 1.5% down
2014$116.46M 63.6% up
2013$71.18M 36.0% up
2012$52.33M 22.1% up
2011$42.87M 27.7% up
2010$33.56M 32.1% up
2009$25.41M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on LAB

Standard BioTools Inc., figure by figure

Standard BioTools Inc. (LAB) overview: price, valuation and scorecard

Standard BioTools Inc. revenue: questions and answers

What is Standard BioTools Inc.'s revenue?

Standard BioTools Inc. (LAB) reported revenue of $85.33M in fiscal 2025 (the year ended December 31, 2025). That is 6.2% lower than the $91.01M of fiscal 2024.

What is the growth rate of Standard BioTools Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 9.2% a year; over ten years the rate was −2.9% a year.

What are the highest and lowest revenue figures on record for Standard BioTools Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $138.14M in fiscal 2020 and the lowest $25.41M in fiscal 2009.

How is Standard BioTools Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Standard BioTools Inc. (LAB) revenue”, data as of 17 November 2026. https://funkfolio.com/stock/LAB/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.